12-Week* Protection With Just 1 Dose
Life-long protection now begins with BRAVECTO®
Deliver the Difference of Bravecto®
Bravecto flea and tick control is helping veterinarians nationwide make a difference in dog and cat owners’ lives with flea and tick control. That’s because only Bravecto (fluralaner) kills fleas and ticks for 12 weeks* with one convenient chew or topical dose.
LONG-LASTING
Potentially fewer gaps in protection with 12-week* flea and tick control
FAST-ACTING
Starts killing fleas and ticks within hours and lasts for 12 weeks*1,3, 8-10
SAFE
Proven safe and effective for both dogs and cats for 12 weeks*1-7
ENHANCES COMPLIANCE
Convenient long-lasting protection means less chance of noncompliance
BRAVECTO Cares from Merck Animal Health is committed to the well-being of all pets. We’re here to help you keep pets happy, healthy and active so owners and their pets can get the most out of their time together.
Hear How Veterinarians Are Enhancing Pet Owner Compliance With Bravecto
“Though we had very high expectations for Bravecto, we were totally blown away with the numbers. The metrics that we saw were double digits – somewhere between 40% and 50% increases when we brought Bravecto onboard.”
Dr. Dan Markwalder
Illinois
Resources
Get
Resources For Your Hospital
Read
Published Bravecto Stories
Share
Your Bravecto Experiences With Us
No items to show.
Introducing the Bravecto® Academy
Access a library of resources to help inform both pet clients and clinical staff about the best topical and oral flea and tick options.
Offer Pet Owner Savings
One dose of Bravecto lasts 12 weeks* compared to monthly products. That already makes it a cost-effective option for pet owners. But now, you can help pet owners save even more on flea and tick control with Bravecto.
Contact Us About the 12-Week* Difference
Contact us for more information about Bravecto for your hospital.
We’ll answer any questions, and help you start prescribing Bravecto for the dogs and cats in your care.
For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.
This site is intended for veterinary professionals. Visit our website for pet parents.
*BRAVECTO kills fleas and prevents flea infestation. Bravecto Chew and Bravecto Topical for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. Bravecto Topical for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.
IMPORTANT SAFETY INFORMATION:
BRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. BRAVECTO Chew: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.
References:
1. Bravecto Chew for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014.
2. Bravecto Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016.
3. Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016.
4. Freedom of Information Summary, NADA 141-426. Approved May 15, 2014.
5. Freedom of Information Summary, NADA 141-459. Approved 2016.
6. Walther FM, Allan MJ, Roepke RKA, Nuernberger MC. Safety of fluralaner chewable tablets (Bravecto™), a novel systemic antiparasitic drug, in dogs after oral administration. Parasites & Vectors (2014) 7:87.
7. Walther FM, Allan MJ, Roepke RKA, Nuernberger MC. Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) collies after oral administration. Parasites & Vectors (2014) 7:86.
8. Burgio et al. Parasites & Vectors (2016) 9:626.
9. Taenzler et al. Parasites & Vectors (2014) 7:567.
10. Wengenmayer et al. Parasites & Vectors (2014) 7:525.
Order Bravecto® for your practice